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Abstract
Background: Coagulase-negative staphylococci (CNS) survive as commensals of skin, anterior nares and external
canals of human and were regarded as non-infectious pathogens. However, they are emerging as a major cause of
nosocomial infectious due to their ability to form biofilms and high resistance to several classes of antibiotics. This
study examines the biofilm forming abilities of 214 clinical CNS isolates using phenotypic and genotypic methods,
and determines their antibiotic susceptibility patterns.
Methods: A total of 214 clinical isolates collected from different clinical samples were identified as CNS and their
antibiotic susceptibility determined by CLSI guidelines. The biofilm forming ability of all isolates was determined by
three phenotypic methods; Congo red agar (CRA) method, tube adherence method (TM) and tissue culture plate
(TCP) method and by genotypic method for the detection of icaAD genes.
Results: Among all the isolates, S. epidermidis (57.5%) was found the most frequently, followed by S. saprophyticus
(18.7%), S. haemolyticus (11.2%), S. hominis (7%), and S. capitis (5.6%). Antibiotic susceptibility pattern demonstrated
91.6% isolates were resistant to penicillin and 66.8% to cefoxitin while 91.1% isolates were susceptible to chloramphenicol. Constitutive and inducible clindamycin resistant phenotype as measured by D-test was seen among 28%
and 14.5% of isolates respectively. Tissue culture plate method detected biofilm production in 42.1% isolate followed
by 31.8% through tube method while 20.1% isolates were found to produce slime in Congo red agar method. The
genotypic assay revealed presence of icaA and icaD genes in 19.2% isolates.
Conclusion: The study shows a high prevalence of biofilm formation and inducible clindamycin resistance in CNS
isolates, indicating the importance of in-vitro biofilm production test and D-test in routine laboratory diagnostics.
Implementation of efficient diagnostic techniques for detection of biofilm production in clinical samples can help
manage staphylococcal infections and minimize risks of treatment failures in hospitals.
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Background
Presently, the wide-spread use of implants in modern
healthcare facilities has substantially increased the risk of
device associated infections, which in turn has drastically
increased the rate of mortality and morbidity. Non-pathogenic indigenous microbiota of skin, nares and other
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mucosal surfaces of human, coagulase-negative staphylococci (CNS) are opportunistic pathogens accounting
as one of the most common etiologic agents of device
related infections [1, 2]. Over the past few decades, CNS,
especially Staphylococcus epidermidis has emerged as a
major cause of nosocomial infections [3–5]. The pathogen, now regarded as a life threatening, causes septicemia, meningitis, endocarditis and other serious invasive
infections. Immunocompromised individuals or patients
undergoing treatment with indwelling devices such as
catheters and tips are more vulnerable to contract the
CNS infections. Therefore, paradoxically, medical devices
aimed to improve the treatment outcome, have often
contributed to the prevalence of nosocomial infections
[1, 5, 6], increasing the clinical significance of CNS.
Biofilm production is one of the major arsenals of saprophytic microbiota to become an opportunistic pathogen [7, 8]. Through biofilms, the CNS can adhere to and
colonize on biotic as well as abiotic surfaces. Likewise,
the damaged host tissue caused by prolonged antibiotic
use and the implanted devices facilitate the survival, proliferation, and virulence of these pathogens [4, 6]. The
biofilm of CNS is composed of the layer of extracellular
polymeric substance called polysaccharide intercellular
adhesion (PIA) matrix, which is encoded by ica operon
(icaADBC genes) [9]. Beneath the biofilm matrix, bacteria are protected from physical, chemical, and biological
stresses imposed by the antibiotics and the host immune
cells [4]. Indeed, increased evidences show that the bacteria embedded within biofilms are difficult to kill by
the antibiotics that are effective against planktonic cells,
leading to the treatment failures of biofilm infections [1,
10, 11]. Moreover, the dispersal phenomenon of biofilms
also serves as a source to metastatic infections [1, 4, 10].
There are mounting evidences of antibiotic resistance
among biofilm forming clinical staphylococcal isolates.
Furthermore, polymicrobial proximity within the biofilm
might facilitate horizontal exchange of genetic information leading to development of antibiotic resistant clonal
population [7]. Therefore, considering the clinical significance of biofilm associated infections, prevention and
management of CNS infections remain a priority for the
betterment of public health. This warrants the implementation of efficient methods to detect biofilm production
among clinical samples in routine laboratory diagnosis.
The antimicrobial susceptibility testing (AST) of a clinical isolate is crucial for the optimal antimicrobial treatment of infected patients. This practice has been even
more critical considering the single or multidrug resistant microorganisms [12]. Studies have reported clinical
antibiotic resistance including that against erythromycin, macrolides, lincosamides and streptogramins type
B (MLSB) in clinical CNS isolates [13, 14]. Many studies
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have reported the prevalence of antibiotic resistance
including MLSB resistance S. aureus isolates from different regions of Nepal [15–22]. Recent studies although
have reported antibiotic resistance and biofilm in clinical CNS isolates [22, 23], the prevalence of M
 LSB resistance in the CNS isolates are lacking in Nepal. Herein, we
report the prevalence of antibiotic resistance and biofilm
production among clinical CNS isolates collected from
two tertiary care hospitals of Nepal.

Methods
Isolation and identification of coagulase‑negative
staphylococci (CNS)

A descriptive cross sectional study was carried out at two
tertiary care hospitals of Nepal; B & B hospital and Kathmandu Institute of Technology (KIST) Medical College
& Hospital. A total of 214 isolates were collected from
various clinical samples including central venous catheter
(CVC), catheter tip, suction tip, drain tip, Double J (DJ)
stent, tracheal tip, endotracheal tip, blood, wound/pus
and urine.
The elution of the bacterial cells from CVC or catheters
was done by following standard microbiological protocol routinely followed in the hospital. The catheter tips
were collected in sterile container and then mixed with
2 ml of nutrient broth (NB). After mixing by vortexing,
loop-full of the suspension was streaked on MacConkey
Agar (MA), Blood Agar (BA) plate and further processed
for bacterial identification. The isolates were identified as
staphylococci according to the standard microbiological
procedure which included colony morphology on BA and
mannitol salt agar (MSA), Gram staining and biochemical tests including catalase, slide and tube coagulase tests
and oxidative/fermentative (O/F) test [25]. Once the isolates were identified as CNS, they were classified into
species following simplified scheme proposed by Cunha
et al., [26] using several biochemical tests. After identification of species, the isolates were stored in tryptic soy
broth (TSB) with glycerol in freezer at −20 °C for further
use.
Phenotypic and genotypic characterization of biofilm
formation

Both phenotypic and genotypic methods were used for
the detection of biofilm production in all the isolates.
ATCC 35983 S. epidermidis strain was used as positive
control for biofilm production in all assays performed.
Congo red agar method (CRA)

The screening of biofilm production was performed
using CRA media; a qualitative method as described by
Freeman et al., [27]. The medium composed of Brain
Heart Infusion (BHI) agar supplemented with sucrose

Manandhar et al. Ann Clin Microbiol Antimicrob

(2021) 20:41

and a dye; Congo red. These plates were inoculated with
CNS isolates, incubated aerobically at 37 ºC for 24 h and
were interpreted based on the qualitative observation of
colored colonies formation on the CRA plates. The black
colonies with dark consistency were regarded as strong
biofilm producers while the pink colonies were regarded
as biofilm non-producers. The experiments were performed in triplicates and repeated three times.
Tube adherence method (TM)

This qualitative method for the detection of biofilm formation was performed as described by Christensen et al.
[28]. A loop-full of microorganism was inoculated in
trypticase soy broth (TSB) supplemented with 1% glucose. The tubes were incubated at 37 ºC for 24 h. The
tubes were decanted, washed with PBS (pH 7.3) for 4
times and dried. Tubes were then stained with 0.1% crystal violet for 15 min. Excess stain was removed by washing with deionized water for 3 times. The tubes were then
dried in inverted position and observed for biofilm formation. In this assay, biofilm formation was considered
positive when a visible film was observed along the inner
wall and bottom of tube. Depending on this, isolates were
scored as 0 for absence, + for weak, +  + for moderate,
and +  +  + for strong biofilm formation. The experiments
were performed in triplicates and repeated three times.
Tissue culture plate (TCP) method

All the isolates were screened for their ability to produce biofilm by this quantitative method as previously
described by Christensen et al. [28] with slight modification [22]. In this assay, a loop-full of organism was inoculated in 5 mL TSB supplemented with 1% glucose and
incubated at 37º C for 24 h. The overnight culture was
diluted 1:100 with fresh media and 0.2 mL of this diluted
culture was inoculated into individual wells of sterile
polystyrene 96 well flat bottom tissue culture plates and
incubated at 37 ºC for 24 h. After incubation, the content
of tissue culture plate was removed by gentle tapping, and
washed with PBS (pH 7.2) 4 times to remove free flowing
planktonic bacteria. Biofilms formed by adherent sessile
bacteria in the plate were fixed with 2% sodium acetate.
It was then stained with 0.1% crystal violet for 15 min at
room temperature. Excess stain was rinsed off by washing
with deionized water for 4 times and plates were dried.
Optical density (OD) of stained adherent bacteria was
measured with micro ELISA auto reader at OD 6
 30 nm.
OD values from sterile medium, fixative and dye were
averaged and subtracted from all test values. The experiments were performed in triplicates and repeated three
times. Bacterial adherence was classified based on OD
values of the individual isolates. Mean OD value < 0.120,
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0.120–0.240 and > 0.240 were classified as non/weak,
moderate and strong biofilm adherence respectively.
Detection of ica genes

The genomic DNA was extracted as previously described
[22] using the DNA extraction Kit (Thermo Fischer). The
sequences of icaA and icaD (accession number U43366)
were taken from the GenBank sequence of the National
Center for Biotechnology Information (NCBI) database.
Primers specific for icaA and icaD were forward 5′-TCT
CTTGCAGGAGCAATCAA, reverse 5′-TCAGGCACT
AACATCCAGCA generating a product size of 188 bp
and
forward
5′-ATGGTCAAGCCCAGACAGAG,
reverse 5′-CGTGTTTTCAACATTTAATGCAA with a
product size of 198 bp respectively [22]. A 25 μl of reaction mixture consisted of MgCl2 (2.5 mM), Taq DNA polymerase (1U), each dNTPs (100 μM), each primer (1 μM)
and DNA extract (200 ng). DNA amplification was carried out with following parameters: preheating at 95 °C
for 5 min followed by 35 cycles of amplification (denaturation at 94 °C for 30 s, annealing at 55 °C for 30 s and
elongation at 72 °C for 30 s) and termination at 72 °C for
2 min. The PCR product was analyzed in 2% agarose gel
stained with SYBR safe dye (Invitrogen).
Antimicrobial susceptibility testing (AST)

AST of the isolates was performed on Mueller Hinton
Agar (MHA) by modified Kirby-Bauer disk diffusion
method recommended by clinical laboratory standard
institution (CLSI) guidelines [29]. The antimicrobial discs
(HiMedia Laboratories) used in the study were: penicillin (10 units), ciprofloxacin (30 µg/disc), tetracycline
(30 µg/disc), clindamycin (2 µg/disc), chloramphenicol
(30 µg/disc), cefoxitin (30 µg/disc), erythromycin (15 µg/
disc), cotrimoxazole (1.25/23.75 µg/disc) and gentamicin
(10 µg/disc). The cefoxitin disc was used to detect methicillin resistance. The Staphylococcus aureus ATCC 25923
was used as reference strain for analyzing AST results.
Screening of inducible clindamycin resistance

The double disc diffusion test or D zone test outlined in
CLSI document M100-S25 [29] was performed to determine if the erythromycin resistant isolates expressed
inducible clindamycin resistance. Erythromycin (15 µg)
disc was placed at a distance of 15 mm (edge to edge)
from clindamycin (2 µg) on Mueller Hinton agar plates
previously inoculated with 0.5 McFarland bacterial suspensions. Plates were analyzed after 18 h of incubation
at 37 °C. Interpretation of the inhibition zone diameters
was as follows: If an isolate was erythromycin resistant
and clindamycin susceptible, with a D-shaped inhibition zone around the clindamycin disc, it was considered positive for inducible resistance (D-test positive,
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iMLSB phenotype). If the isolate was erythromycin
resistant and clindamycin susceptible, with both zones
of inhibition showing a circular shape, the isolate was
considered to be negative for inducible resistance (D
test negative, MS phenotype), but to have an active
efflux pump. If the isolate was resistant to both drugs,
it was considered to have the macrolide–lincosamide–
Streptogramin B constitutive (cMLSB phenotype) [30].
Statistical analysis

The statistical analysis was performed using SPSS
17.0 (SPSS Inc., Chicago, USA) software. Chi-square
test was used to compare between groups and P values < 0.05 were considered statistically significant.
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Frequency of CNS isolated from different clinical
specimens

S. epidermidis was isolated from all specimen types
received in the laboratory. It was most frequently isolated from blood (52, 42.3%) followed by wound/pus
(34, 27.6%). Similarly, S. saprophyticus was also mostly
isolated from blood (12, 30%) and wound/pus (12, 30%).
Different implant devices were also found to harbor CNS.
All CNS were isolated from catheter tip except S. hominis. However, S. hominis were isolated from CVC, blood,
wound/pus and urine. On the other hand, S. saprophyticus and S. haemolyticus were not isolated from suction
tip, drain tip, tracheal tip and endotracheal tip. Similarly,
S. capitis were isolated only from CVC, catheter tip,
blood, and wound/pus (Table 1).
Antibiotic susceptibility pattern among CNS isolates

Results
Isolation and identification of CNS

A total of 214 isolates were identified as CNS from various clinical samples following standard microbiological
procedure using different biochemical tests [25]. Five
species were identified among all CNS isolates including S. epidermidis (57.5%); the most frequently isolated
species followed by S. saprophyticus (18.7%), S. haemolyticus (11.2%), S. homonis (7%) and S. captis (5.6%)
(Fig. 1).

Antibiotic susceptibility testing of 9 clinically relevant
antibiotics was performed against all the collected isolates. These antibiotics were selected because of their
common use in clinical practice in hospitals of Nepal.
Among all CNS, 91.6% isolates were found to be resistant to penicillin. Mostly, S. epidermidis (114, 92.7%), S.
saprophyticus (35, 87.5%) and S. haemolyticus (23, 95.8%)
were susceptible to chloramphenicol. Similarly, S. capitis
(12, 100%) and S. hominis (14, 93.3%) were susceptible to
tetracycline (Table 2). Cefoxitin disc was used to detect
methicillin resistance, which was observed in 66.8% CNS
isolates. All five CNS species were found to be methicillin resistant with 73 (59.3%) S. epidermidis, 29 (72.5%) S.
saprophyticus, 21 (87.5%) S. haemolyticus, 10 (66.7%) S.
hominis and 10 (83.3%) S. capitis (Table 2).
Inducible clindamycin resistance

Fig. 1 Percentage of CNS isolated from various clinical samples

Clindamycin is a useful drug in the treatment of serious
infections caused by Staphylococci due to its excellent
tissue penetration, good oral absorption, and is an alternative to penicillin allergic patients. However, it has been
indicated that approximately 45% of erythromycin resistant S. aureus isolates have inducible M
 LSB resistance that

Table 1 Frequency of CNS isolated from different clinical specimens
CNS

Clinical specimen
CVC

Catheter tip

Total
Blood

Wound/pus

Urine

Others

S. epidermidis

8 (6.5%)

14 (11.4%)

52 (42.3%)

34 (27.6%)

11(8.9%)

4 (3.3%)

123 (57.5%)

S. saprophyticus

2 (5.0%)

2 (5.0%)

12 (30.0%)

12 (30.0%)

11(27.5%)

1(2.5%)

40 (18.7%)

S. hemolyticus

6 (25.0%)

6 (25.0%)

5 (20.8%)

5 (20.8%)

1(4.2%)

1(4.2%)

24 (11.2%)

S. hominis

1 (6.7%)

–

10 (66.7%)

3 (20.0%)

1 (6.7%)

–

15 (7.0%)

S. capitis

3 (25.0%)

3 (25.0%)

3 (25.0%)

2 (16.7%)

–

1(8.3%)

12 (5.6%)

CVC central venous catheter; others (Suction tip, Drain tip, Double J stent, Tracheal tip, Endotracheal tube)

18 (8.4%)

59 (27.6%)

134 (62.6%)

169 (79%)

155 (72.4%)

80 (37.4%)

45 (21%)

Erythromycin

Cotrimoxazole

R Resistant, S Sensitive

Gentamicin

71 (33.2%)

19 (8.9%)

143 (6.5%)

Chloramphenicol

Cefoxitin

187 (87.4%)

195 (91.1%)

151 (70.6%)

27 (12.6%)

63 (29.4%)

Clindamycin

138 (64.5%)

Tetracycline

196 (91.6%)

76 (35.5%)

Penicillin

111 (90.2%)

17 (13.8%)

46 (37.4%)

80 (65%)

73 (59.3%)

9 (7.3%)

30 (24.4%)

11 (8.9%)

39 (31.7%)

106 (86.2%)

77 (62.6%)

43 (35%)

50 (40.7%)

114 (92.7%)

93 (75.6%)

112 (91.1%)

84 (68.35)

12 (9.8%)

S

R

R

S

S. epidermidis (n = 123)

Total (n = 214)

Ciprofloxacin

CNS

Antibiotics

Table 2 Antimicrobial susceptibility pattern of CNS isolates

8 (20%)

14 (35%)

34 (85%)

29 (72.5%)

5 (12.5%)

13 (32.5%)

8 (20%)

7 (17.5%)

39 (97.5%)

R

32 (80%)

26 (65%)

6 (15%)

11 (27.5%)

35 (87.5%)

27 (67.5%)

32 (80%)

33 (82.5%)

1 (2.5%)

S

S. saprophyticus (n = 40)

14 (58.3%)

10 (41.7%)

21 (87.5%)

21 (87.5%)

1 (4.2%)

9 (37.5%)

7 (29.2%)

17 (70.8%)

23 (95.8%)

R

10 (41.7%)

14 (58.3%)

3 (12.5%)

3 (12.5%)

23 (95.8%)

15 (62.5%)

17 (70.8%)

7 (29.2%)

1 (4.2%)

S

S. hemolyticus (n = 24)

–

6 (40%)

10 (66.7%)

10 (66.7%)

2 (13.3%)

5 (33.3%)

1 (6.7%)

5 (33.3%)

12 (80%)

R

15 (100%)

9 (60%)

5 (33.3%)

5 (33.3%)

13 (86.7%)

10 (66.7%)

14 (93.3%)

10 (66.75)

3 (20%)

S

S. hominis (n = 15)

6 (50%)

4 (33.3%)

10 (83.3%)

10 (83.3%)

2 (16.7%)

6 (50%)

-

8 (66.7%)

11 (91.7%)

R

6 (50%)

8 (66.7%)

2 (16.7%)

2 (16.7%)

10 (83.3%)

6 (50%)

12 (100%)

4 (33.3%)

1 (8.3%)

S

S. capitis (n = 12)
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would go unrecognized if erythromycin and clindamycin
disc are not placed appropriately during routine antibiotic susceptibility test [29, 31]. Among 214 CNS, 155
(72.4%) were resistant to erythromycin. MS phenotype
(D test) was performed for these isolates and showed
that 60 (28%) isolates were resistant to both erythromycin and clindamycin indicating constitutive MLSB phenotype. Out of 151 clindamycin sensitive isolates, positive
D test was observed among 31(14.5%) isolates, indicating
inducible MLSB phenotype. Negative D-test results were
obtained among 70 (32.7%) isolates, whereas, the remaining 53 (24.8%) isolates were susceptible to both erythromycin and clindamycin. Constitutive and inducible
MLSB phenotype was 51 (23.8%) and 25 (11.7%) among
methicillin resistant CNS and 9 (4.2%) and 6 (2.8%) in
methicillin sensitive CNS respectively. Both constitutive
and inducible MLSB phenotype was predominant among
MRCNS as compared to MSCNS (Table 3).
Biofilm formation among CNS isolates

Biofilm production was assessed by both phenotypic and
genotypic methods. The slime production ability of identified clinical CNS isolates was screened by CRA method.
Among 214 CNS, 20 (9.3%) isolates produced black colonies indicating strong positive for polysaccharide production. The qualitative assessment of the amount of biofilm
production was done by tube adherence method (TM)
which showed strong production (+ + +) among 44
(20.6%) isolates and moderate biofilm production among
24 (11.2%) isolates. Biofilm production was determined
quantitatively by tissue culture plate (TCP) method that
demonstrated strong and moderate biofilm producers in
35 (16.4%) and 55 (25.7%) CNS isolates. Among all CNS
species, S. epidermidis was the most frequent species to
produce biofilm in all phenotypic methods. In addition,
genotypic assay also revealed this species harboring both
icaA and icaD genes more frequently. The ica genes were
detected in 41 (19.2%) of all CNS isolates. Among all
methods, TCP detected biofilm production in a greater
number of isolates in all species (Table 4).

Determination of biofilm formation among methicillin
resistant CNS isolates

The biofilm production as detected by different phenotypic methods were higher in methicillin resistant than
methicillin sensitive isolates but was not found to be
statistically significant. Similarly, the ica genes were also
found in higher number among methicillin resistant CNS
than methicillin sensitive CNS but it was not found to be
statistically significant (Table 5).
The icaAD genes are present in all clinical sample type

The study revealed that 14 (17.07%) CNS isolates from
blood samples (n = 82) and 14 (25%) from wound/pus
samples (n = 56) harbored ica genes. Likewise, ica genes
were also present in six (30%) biomaterial isolates collected from CVC (n = 20), four (16%) from catheters
(n = 23), and one each from DJ stenting (n = 2), ET tip
(n = 1), and urine samples (n = 24) (Fig. 2). The identification of icaAD genes was done by PCR of DNA extracted
from the CNS isolates using the primer listed in method
section (Fig. 3).
Antibiotic susceptibility pattern of isolates that harbor ica
genes

The antibiotic susceptibility patterns of the isolates harboring ica genes were determined. The study showed no
significant difference in antibiotic susceptibility between
icaAD positive and icaAD negative isolates. Methicillin
resistance was observed more among the isolates harboring ica genes than those lacking it. Altogether, the result
shows that not only biofilm formation but other factors
are responsible for antibiotic resistance among CNS
(Table 6).

Discussion
The coagulase-negative staphylococci (CNS) including
S. epidermidis are ubiquitous in nature; reside on the
skin of healthy individuals as normal flora. In fact, due
to this phenomenon, CNS has been emerged as common nosocomial pathogens. In addition, the ability to

Table 3 Erythromycin and clindamycin susceptibility testing
Phenotypes

MRCNS
(n)

MSCNS
%

Total

(n)

%

(n)

%

E-S, CD-S

18

8.4

35

16.4

53

24.8

E-R, CD-R (constitutive MLSB)

51

23.8

9

4.2

60

28

E-R, CD-S (inducible MLSB, D-positive)

25

11.7

6

2.8

31

14.5

E-R, CD-S (MS, D-negative)

49

22.9

21

9.8

70

32.7

143

66.8

71

33.2

214

100

Total

MRCNS Methicillin resistant CNS, MSCNS Methicillin sensitive CNS, E Erythromycin, CD Clindamycin, R Resistant, S Sensitive, MLSB Macrolides, Lincosamides and
Streptogramin B
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Table 4 Determination of biofilm formation in CNS by genotypic and phenotypic methods
Biofilm

CNS isolates

Total (n = 214)

S. epidermidis

S. saprophyticus

S. haemolyticus

S. hominis

S. capitis

(n = 123)

(n = 40)

(n = 24)

(n = 15)

(n = 12)

Strong

12 (9.8%)

2 (5.0%)

3 (12.5%)

3 (20.0%)

-

20 (9.3%)

Moderate

12 (9.8%)

2 (5.0%)

5 (20.8%)

2 (13.3%)

2 (16.7%)

23 (10.7%)

Weak/none

99 (80.5%)

36 (90.0%)

16 (66.7%)

10 (66.7%)

10 (83.3%)

171 (79.9%)

Congo red agar (CRA)

Tube adherence method (TM)
Strong

33 (26.8%)

4 (10.0%)

2 (8.33%)

3 (20.0%)

2 (16.7%)

44 (20.6%)

Moderate

9 (7.3%)

6 (15.0%)

6 (25.0%)

3 (20.0%)

-

24 (11.2%)

Weak/none

81 (65.9%)

30 (75.0%)

16 (66.7%)

9 (60.0%)

10 (83.3%)

146 (68.2%)

Strong

23 (18.7%)

8 (20.0%)

3 (12.5%)

1 (6.7%)

-

35 (16.4%)

Moderate

32 (26.0%)

9 (22.5%)

4 (16.7%)

7 (46.7%)

3 (25.0%)

55 (25.7%)

Weak/none

68 (55.3%)

23 (57.5%)

17 (70.8%)

7 (46.7%)

9 (75.0%)

124 (57.9%)

Present

29 (23.6%)

5 (12.5%)

2 (8.33%)

3 (20.0%)

2 (16.7%)

41 (19.2%)

Absent

94 (76.4%)

35 (87.5%)

22 (91.7%)

12 (80.0%)

10 (83.3%)

173 (80.8%)

Tissue culture plate (TCP)

ica gene

Table 5 Biofilm formation in CNS in relation to methicillin
susceptibility
Biofilm

MRCNS

MSCNS

Congo red agar (CRA)

p-value
0.322

Present

26 (18.2%)

17 (23.9%)

Absent

117 (81.8%)

54 (76.1%)

Tube adherence method (TM)

0.447

Present

43 (30.1%)

25 (35.2%)

Absent

100 (69.9%)

46 (64.8%)

Present

58 (40.6%)

32 (45.1%)

Absent

85 (59.4%)

39 (54.9%)

Present

28 (19.6%)

13 (18.3%)

Absent

115 (80.4%)

58 (81.7%)

Tissue culture plate (TCP)

0.529

ica genes

0.824

MRCNS Methicillin resistant CNS, MSCNS Methicillin sensitive CNS

form biofilms on biotic as well as abiotic surfaces have
made them successful human pathogens causing persistent infections leading to serious health problems.
Given that biofilm is an important virulence factor that
is mostly associated with antibiotic resistance for these
pathogens, early detection in clinical specimen would
impose significant impact in management of staphylococcal nosocomial infections. Taking this into consideration, the study was carried out to investigate the
prevalence of biofilm producing CNS and antibiotic

Fig. 2 Distribution of CNS isolates possessing ica genes in different
clinical specimens

icaD

icaA

200 bp

Fig. 3 Representative picture of PCR amplification of icaA (188 bp)
and icaD (198 bp) genes in CNS isolates
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Table 6 Antibiotic susceptibility pattern of ica positive isolates
Antibiotics

ica genes

p-value

Present
Susceptible
Penicillin

Absent
Resistant

Susceptible

Resistant

4 (1.9%)

37 (17.3%)

14 (6.5%)

159 (74.3%)

0.119

Ciprofloxacin

28 (13.1%)

13 (6.1%)

110 (51.4%)

63 (29.4%)

0.334

Tetracycline

38 (17.8%)

3 (1.4%)

149 (69.6%)

24 (11.2%)

6.590

Clindamycin

32 (15.0%)

9 (4.2%)

119 (55.6%)

54 (25.2%)

3.332

Chloramphenicol

38 (17.8%)

3 (1.4%)

157 (73.4%)

16 (7.5%)

0.231

Cefoxitin

13 (6.1%)

28 (13.1%)

58 (27.1%)

115 (53.7%)

0.049

Erythromycin

15 (7.0%)

26 (12.1%)

44 (20.6%)

129 (60.3%)

2.256

Cotrimoxazole

29 (13.6%)

12 (5.6%)

105 (49.1%)

68 (31.8%)

1.460

Gentamicin

35 (16.4%)

6 (2.8%)

134 (62.6%)

39 (18.2%)

1.464

resistant strains in different clinical samples collected
from two tertiary care hospitals of Nepal.
Among 214 CNS, S. epidermidis was the most common isolate accounting for more than half (57.4%) of
total numbers (n = 123) followed by S. saprophyticus
(n = 40, 18.6%), S. haemolyticus (n = 24, 11.2%), S. hominis (n = 15, 7%) and S. capitis (n = 12, 5.6%) (Table 1).
Previous studies have also reported S. epidermidis as the
most common isolates among CNS [24, 32–34]. While S.
epidermidis was isolated form all clinical samples, it was
more commonly isolated from blood, wound/pus. S. saprophyticus along with blood and wound/pus was also isolated from urine. The high number of S. saprophyticus in
urine is consistent with the previous studies [24, 35] may
be due to its adhering capacity to wall of urinary tract.
Importantly, all CNS species were isolated from different
medical devices indicating their ability to cause device
associated infections.
Antibiotic resistance is a major human health problem.
The present result also demonstrated that majority of
isolates were 91.6% and 72.4% resistant to penicillin and
erythromycin respectively. However, the study also demonstrated majority of isolates being susceptible to chloramphenicol (91.1%) and tetracycline (87.4%). Such high
frequency of susceptibility pattern of chloramphenicol is
consistent with the previous study by [24, 33, 36, 37], but
their study showed lower susceptibility in case of erythromycin and penicillin. Indeed, similar susceptibility profile for all CNS strains was found as that of S. epidermidis
strains. This indicates CNS are still susceptible to the first
line drug and being cheap, these antibiotics could be used
for the treatment of CNS infections caused by CNS in a
resource limiting country like Nepal.
Among all CNS isolates, constitutive MLSB were present among 51 (23.8%) isolates and inducible M
 LSB
among 25 (11.7%) isolates. While similar frequency of

inducible MLSB was demonstrated by Perez et al., [38] as
high as 50% CNS were found to be positive in study by
Schreckenberger et al., [14]. These results indicate that
constitutive and inducible MLSB resistance is dependent on the hospitals and the geographical area. Nonetheless, chances of inducible M
 LSB can be reduced by
implementing reliable diagnostics of M
 LSB in the clinical
samples.
Biofilm formation remains the most important mechanism of pathogenicity among staphylococci [10].
Although CRA and TM methods detected the biofilm
production in a smaller number of isolates, TCP method
was able to detect biofilm production in 90 (42.1%) isolates. Similar frequency of biofilm production in clinical
CNS isolates was reported previously [39–41]. However,
the higher frequency (65.38%) of biofilm production was
reported by Shrestha et al., [23] in a study, conducted
in tertiary care hospital of eastern Nepal as well as the
study by Oliveira et al., [42], who reported 75% of CNS
producing biofilm. Likewise, PCR amplification in our
study revealed only 41 (19.2%) isolates possessing both
icaA and icaD genes. This rate is lower as compared to
the previous studies [33, 40]. The possible reasons are
the various factors such as environment, nutrition, subinhibitory concentration of certain antibiotics, and stress
(temperature, osmolarity) might play a significant role in
biofilm formation resulting in varied frequency of biofilm
producers among clinical isolates [43–47].
Among 41 icaAD positive isolates, only 7 (17%) showed
the positive result in CRA method. This is in contrast to
the previous studies by Zhou et al., [48] who reported all
icaAD positive isolates also produced black colonies on
CRA method. Similarly, good correspondence between
possession of icaAD genes and CRA positivity was
reported by de Silva et al., [2]. Our result shows that not
all biofilm producers as per phenotypic assays possessed

Manandhar et al. Ann Clin Microbiol Antimicrob

(2021) 20:41

ica genes. Several previous studies have reported this
phenomenon [49–52]. We speculated that while most
of the staphylococcal isolates which form biofilm are
dependent on the icaAD genes, other factors such as
teichoic acids also contribute to form biofilm [33]. It may
also be possible that inactivation of ica operon occurs
due to the insertion of the IS256 insertion sequence.
Similarly, the ica-negative, non-slime-producing isolates
likely represent strains with alternate means of adhesion,
such as microbial surface components recognizing adhesive matrix molecules (MSCRAMMs). These findings
reinforce the opinion that several mechanisms besides
slime production are responsible for bacterial adhesion
and hence biofilm production [43].
Our study revealed ica genes were present mostly
among blood and wound/pus samples (14 isolates each).
Our results are consistent with the study previously performed [40] where quarter of the isolates from blood
cultures and catheter tips produced biofilm. However,
in contrast, we detected lesser frequency of biofilm production in the biomaterial sample like CVC, catheter,
DJ stenting and ET tip. Interestingly, we did not observe
significant difference of antibiotic resistance among biofilm producers and non-producers. Similar results were
also reported previously [53] with no difference in antimicrobial resistance between biofilm-producing and
non-producing S. epidermidis. Nonetheless, altogether,
the percentage of biofilm production was higher among
S. epidermidis than in other CNS isolates indicating that
biofilm production is an important virulence factor for
the pathogenicity of S. epidermidis. However, the results
also support the idea that neither biofilm nor the icaAD
genes could alone be used as biomarker of clinical significance, as suggested previously [2].

Conclusion
This study identified S. epidermidis as the most frequent
species (57.5%) with the highest rate of biofilm production in all CNS examined. Among all phenotypic methods, TCP method detected biofilm production in higher
percentage of CNS. We observed high prevalence of
methicillin resistance as well as the presence of both
constitutive and inducible M
 LSB phenotype in these
clinical CNS isolates. However, the result showed no significant difference in the prevalence of antibiotic resistance between biofilm producers and non-producers
CNS.
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